{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:33:19Z","timestamp":1793741599921,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.msard.2021.102757","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T02:38:50Z","timestamp":1610937530000},"page":"102757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-0911","authenticated-orcid":false,"given":"Abdorreza Naser","family":"Moghadasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Mirmosayyeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Ghajarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2021.102757_bib0001","doi-asserted-by":"crossref","unstructured":"Altunrende, B., Yabalak, A., Polat, E., Kocaslan, M., Topcular, B., Demir, A.G. Cognitive profile in neuromyelitis optica spectrum disorder. 2016.","DOI":"10.1016\/j.jns.2017.08.681"},{"issue":"4","key":"10.1016\/j.msard.2021.102757_bib0002","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1212\/NXI.0000000000000580","article-title":"Neuromyelitis optica spectrum disorder: patient experience and quality of life","volume":"6","author":"Beekman","year":"2019","journal-title":"Neurol.-Neuroimmunol. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.msard.2021.102757_bib0003","doi-asserted-by":"crossref","first-page":"e33878","DOI":"10.1371\/journal.pone.0033878","article-title":"White matter atrophy and cognitive dysfunctions in neuromyelitis optica","volume":"7","author":"Blanc","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.msard.2021.102757_bib0004","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneurol.2007.16","article-title":"Cognitive functions in neuromyelitis optica","volume":"65","author":"Blanc","year":"2008","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2021.102757_bib0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1352458506070725","article-title":"Brain magnetic resonance imaging findings in relapsing neuromyelitis optica","volume":"13","author":"Cabrera-G\u00f3mez","year":"2007","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2021.102757_bib0006","series-title":"Global and Regional Hippocampal Volumes Are Preserved in Neuromyelitis Optica and Do not Seem to Be Related to Cognitive Impairment (P1. 2-073)","author":"Cacciaguerra","year":"2019"},{"issue":"6","key":"10.1016\/j.msard.2021.102757_bib0007","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1468-1331.2010.03252.x","article-title":"Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica","volume":"18","author":"Chanson","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2021.102757_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102406","article-title":"Visual system damage and network maladaptation are associated with cognitive performance in neuromyelitis optica spectrum disorders","volume":"45","author":"Chavarro","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"10.1016\/j.msard.2021.102757_bib0009","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s00415-019-09438-2","article-title":"Screening for cognitive impairment among patients with neuromyelitis optica using touchscreen cognitive testing in routine clinical care","volume":"266","author":"Cotter","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2021.102757_bib0010","doi-asserted-by":"crossref","first-page":"e01842","DOI":"10.1002\/brb3.1842","article-title":"Cognitive impairment in NMOSD\u2014more questions than answers","author":"Czarnecka","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.msard.2021.102757_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102128","article-title":"Evaluation of types of psychological disorders in patients with neuromyelitis optica spectrum disorder (NMOSD)","author":"Ebadi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2021.102757_bib0012","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.msard.2017.10.003","article-title":"Cognitive impairment in neuromyelitis optica spectrum disorders: what do we know?","volume":"18","author":"Eizaguirre","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2021.102757_bib0013","article-title":"Cognitive impairment in neuromyelitis optica and multiple sclerosis","author":"Fernandez Diaz","year":"2017","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2021.102757_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ensci.2017.09.001","article-title":"Cognitive impairment in neuromyelitis optica spectrum disorders: a comparison of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale Revised with the Rao Brief Repeatable Neuropsychological Battery","volume":"9","author":"Fujimori","year":"2017","journal-title":"Eneurologicalsci"},{"issue":"12","key":"10.1016\/j.msard.2021.102757_bib0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3109\/00207454.2011.608456","article-title":"Cognitive function, depression, fatigue, and activities of daily living in patients with neuromyelitis optica after acute relapse","volume":"121","author":"He","year":"2011","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.msard.2021.102757_bib0016","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bandc.2011.05.007","article-title":"Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse","volume":"77","author":"He","year":"2011","journal-title":"Brain Cogn."},{"key":"10.1016\/j.msard.2021.102757_bib0017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2016.01.010","article-title":"Cognition, mood, and purpose in life in neuromyelitis optica spectrum disorder","volume":"362","author":"Hollinger","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.msard.2021.102757_bib0018","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/ene.13224","article-title":"Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"24","author":"Hyun","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2021.102757_bib0019","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.msard.2021.102757_bib0020","first-page":"S401","article-title":"A longitudinal study of cognitive functions in patients with neuromyelitis optica","volume":"17","author":"Jung","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2021.102757_bib0021","series-title":"Multiple Sclerosis","article-title":"Cerebral volume and cognitive functions in neuromyelitis optica","author":"Jung","year":"2009"},{"issue":"20","key":"10.1016\/j.msard.2021.102757_bib0022","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.2169\/internalmedicine.53.2571","article-title":"Cognitive and affective assessments of multiple sclerosis (MS) and neuromyelitis optica (NMO) patients utilizing computerized touch panel-type screening tests","volume":"53","author":"Kawahara","year":"2014","journal-title":"Intern. Med."},{"issue":"6","key":"10.1016\/j.msard.2021.102757_bib0023","article-title":"Comparison of cognitive performance and mri-measured brain volume and cortical thickness between patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS): a preliminary report","volume":"21","author":"Kim","year":"2015","journal-title":"Mult. Scler. J."},{"issue":"14","key":"10.1016\/j.msard.2021.102757_bib0024","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1177\/1352458516636246","article-title":"Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"22","author":"Kim","year":"2016","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.msard.2021.102757_bib0025","first-page":"1","article-title":"Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2021.102757_bib0026","series-title":"ECTRIMS 2016 & 21st Annual Conference of Rehabilitation","article-title":"Cognitive impairment of Chinese patients with multiple sclerosis and neuromyelitis optica","author":"Leung","year":"2016"},{"issue":"4","key":"10.1016\/j.msard.2021.102757_bib0027","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0404.2008.01012.x","article-title":"Brain magnetic resonance imaging abnormalities in neuromyelitis optica","volume":"118","author":"Li","year":"2008","journal-title":"Acta Neurol. Scand."},{"issue":"17","key":"10.1016\/j.msard.2021.102757_bib0028","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1212\/WNL.0000000000002067","article-title":"Structural MRI substrates of cognitive impairment in neuromyelitis optica","volume":"85","author":"Liu","year":"2015","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.msard.2021.102757_bib0029","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0b013e3182887957","article-title":"Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution","volume":"80","author":"Matthews","year":"2013","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2021.102757_bib0030","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00415-016-8345-3","article-title":"Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis","volume":"264","author":"Meng","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2021.102757_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102669","article-title":"Screening neuromyelitis optica patients for COVID-19 infection","author":"Mirmosayyeb","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.msard.2021.102757_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147601","article-title":"Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis","volume":"11","author":"Modesti","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2021.102757_bib0033","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2015.11.031","article-title":"Cognitive and psychiatric comorbidities in neuromyelitis optica","volume":"360","author":"Moore","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2021.102757_bib0034","article-title":"Neuropsychiatric features of neuromyelitis optica","author":"Moore","year":"2014","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2021.102757_bib0035","unstructured":"Orviz Garcia, A., Valles Salgado, M., Matias-Guiu Antem, J., Gonzalez-Suarez, I., Oreja-Guevara, C.. Is cognitive impairment common in neuromyelitis optica spectrum disorders (NMOSD)? 2016."},{"issue":"12","key":"10.1016\/j.msard.2021.102757_bib0036","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1007\/s00330-016-4282-x","article-title":"Brain parenchymal damage in neuromyelitis optica spectrum disorder\u2013a multimodal MRI study","volume":"26","author":"Pache","year":"2016","journal-title":"Eur. Radiol."},{"issue":"7","key":"10.1016\/j.msard.2021.102757_bib0037","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2021.102757_bib0038","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.23721","article-title":"Cognitive impairment and cortical degeneration in neuromyelitis optica","volume":"73","author":"Saji","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2021.102757_bib0039","article-title":"Characteristic features of cognitive dysfunction in neuromyelitis optica","author":"Saji","year":"2011","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2021.102757_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105621","article-title":"Cognitive functions in Egyptian neuromyelitis optica spectrum disorder","volume":"189","author":"Salama","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"6","key":"10.1016\/j.msard.2021.102757_bib0041","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1590\/0004-282X20130038","article-title":"Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis","volume":"71","author":"Vanotti","year":"2013","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2021.102757_bib0042","series-title":"Towards the Search for a Cognitive Pattern in Neuromyelitis Optica and Its Impact in Quality of Life (P02. 039)","author":"Vanotti","year":"2012"},{"key":"10.1016\/j.msard.2021.102757_bib0043","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejrad.2017.08.012","article-title":"Abnormal brain function in neuromyelitis optica: a fMRI investigation of mPASAT","volume":"95","author":"Wang","year":"2017","journal-title":"Eur. J. Radiol."},{"issue":"14","key":"10.1016\/j.msard.2021.102757_bib0044","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1177\/1352458515576982","article-title":"Cognitive impairment in Chinese neuromyelitis optica","volume":"21","author":"Zhang","year":"2015","journal-title":"Mult. Scler. J."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:56:04Z","timestamp":1761900964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":44,"alternative-id":["S2211034821000237"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.102757","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.102757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102757"}}